Clinical Trial Information Request for Protocol 25-051 Title MagnetisMM-32: A Study Comparing the Study Medicine called Elranatamab versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) or Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in People With Multiple Myeloma That Has Come Back After Prior Treatment(s) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone